FDA Drug Shortages (New and Updated) - August 30, 2022

If your email program has trouble displaying this email, view as a webpage. Thank you for subscribing to our newsletter. In an effort to consolidate information and effectively communicate with you, this newsletter will be eliminated after Sept. 30, 2022. As a result, you will find this information in the CDER New bulletin (example from July 21, 2022).   Subscribe to CDER New bulletin Drug Shortages FDA Drug Shortages Fenoldopam Mesylate (Corlopam) Injection (New - Discontinuation) Procainamide Hydrochloride Injection (New - Discontinuation) Remifentanil Injection (Updated - Currently in Shortage) Synercid Injection (New -Discontinuation) Vecuronium Bromide for Injection (Updated - Currently in Shortage)

Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA